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Culturing newly identified human lung pathogens from clinical sample isolates can represent a daunting
task, with problems ranging from low levels of pathogens to the presence of growth suppressive factors in the
specimens, compounded by the lack of a suitable tissue culture system. However, it is critical to develop
suitable in vitro platforms to isolate and characterize the replication kinetics and pathogenesis of recently
identified human pathogens. HCoV-HKU1, a human coronavirus identified in a clinical sample from a patient
with severe pneumonia, has been a major challenge for successful propagation on all immortalized cells tested
to date. To determine if HCoV-HKU1 could replicate in in vitro models of human ciliated airway epithelial cell
cultures (HAE) that recapitulate the morphology, biochemistry, and physiology of the human airway epithe-
lium, the apical surfaces of HAE were inoculated with a clinical sample of HCoV-HKU1 (Cean1 strain). High
virus yields were found for several days postinoculation and electron micrograph, Northern blot, and immu-
nofluorescence data confirmed that HCoV-HKU1 replicated efficiently within ciliated cells, demonstrating that
this cell type is infected by all human coronaviruses identified to date. Antiserum directed against human
leukocyte antigen C (HLA-C) failed to attenuate HCoV-HKU1 infection and replication in HAE, suggesting
that HLA-C is not required for HCoV-HKU1 infection of the human ciliated airway epithelium. We propose
that the HAE model provides a ready platform for molecular studies and characterization of HCoV-HKU1 and
in general serves as a robust technology for the recovery, amplification, adaptation, and characterization of
novel coronaviruses and other respiratory viruses from clinical material.
About 335 new or emerging infectious diseases have been
identified since 1940 (23), and while many threaten human
health, the global economy, and national security, respiratory
pathogens are of particular public health concern. Using mod-
ern methods, several previously unknown viruses have been
identified, including respiratory pathogens (1, 18, 27, 54, 57),
yet research remains restricted to prevalence and disease as-
sociation studies since a virus culture system is oftentimes
lacking. Immortalized tissue culture cells are adapted to
growth in laboratory conditions and, as such, display altered
gene expression patterns, which may not be optimal for the
replication of fastidious viruses. Primary cell-differentiated cul-
ture models provide alternative in vitro model systems closer in
nature to the in vivo host tissue environment for infection
studies and amplification of pathogens for further character-
ization. Here, we use an in vitro model of human ciliated airway
epithelial cell cultures (HAE) that mimic the properties of the
cartilaginous airway epithelium (17) to culture the previously
unculturable human coronavirus HKU1 (HCoV-HKU1).
Coronaviruses are important pathogens of humans and an-
imals, causing a range of symptoms depending on the host.
Following the severe acute respiratory syndrome (SARS)-CoV
epidemic, several new strains of human coronaviruses were
identified by molecular techniques, including HCoV-NL63,
identified in the Netherlands from an infant with bronchiolitis
(54), and HCoV-HKU1, identified in an adult patient with
severe pneumonia in Hong Kong (57). HCoV-NL63 has been
demonstrated to infect and replicate in both conventional im-
mortalized cells and human ciliated airway cell cultures, pro-
ducing sufficient amounts of virus for characterization studies
of viral replication and pathogenesis and the successful devel-
opment of an infectious clone (3, 13, 22, 41). In contrast, little
is known about HCoV-HKU1, as no in vitro replication model
has been identified to date, limiting further investigations of
the virus.
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Clinical isolates of previously isolated human coronaviruses
have been adapted to replicate in standard transformed cell
culture; for example, SARS-CoV and HCoV-NL63 replicate
efficiently in epithelial monkey kidney cells (VeroE6 and LLC-
MK2), HCoV-OC43 in BHK21 cells, and HCoV-229E in
MRC5 cells (14, 24, 35, 47, 54, 59). Despite the successful
amplification of these human coronaviruses in cell lines, all
attempts to date to culture a clinical isolate of HCoV-HKU1
have failed. No HCoV-HKU1 genomic replication was ob-
served after inoculation of standard cell lines previously uti-
lized for virus propagation, including RD (human rhabdomyo-
sarcoma cells), HRT-18 (colorectal adenocarcinoma cells),
HEp-2 (human epithelial carcinoma cells), MRC-5 (human
lung fibroblast cells), A549 (human lung epithelial adenocar-
cinoma cells), Caco2 (human colorectal adenocarcinoma
cells), Huh-7 (human hepatoma cells), B95a (marmoset B-
lymphoblastoid cells), mixed neuron-glia culture, LLC-MK2
(rhesus monkey kidney cells), FRhK-4 (rhesus monkey kidney
cells), BSC-1 (African green monkey kidney cells), Vero E6
(African green monkey kidney cells), MDCK (Madin-Darby
canine kidney cells), I13.35 (murine macrophage cells), and
L929 (murine fibroblast cells) (57).
Here, we use human ciliated airway epithelial cell cultures to
successfully propagate HCoV-HKU1 for the first time in vitro.
In this culture model, HCoV-HKU1 genome copy numbers
increased by several logs over the initial three-day incubation
period and electron micrograph, Northern blot, and immuno-
fluorescence data confirmed HKU1 replication in HAE and
that ciliated cells were the preferential target for virus infec-
tion, the same cell type infected by all human coronaviruses
tested so far in these model systems.
MATERIALS AND METHODS
Human tracheobronchial epithelial cultures and clinical virus isolate. Human
tracheobronchial epithelial cells were obtained from airway specimens resected
from patients undergoing surgery under University of North Carolina Institu-
tional Review Board-approved protocols by the Cystic Fibrosis Center Tissue
Culture Core. Primary cells were expanded on plastic to generate passage 1 cells
and plated at a density of 2.5  105 cells per well on permeable Transwell-COL
(12-mm-diameter) supports. Human airway epithelium cultures were generated
by provision of an air-liquid interface for 4 to 6 weeks to form well-differentiated,
polarized cultures that resemble in vivo pseudostratified mucociliary epithelium
(17). A sample containing HCoV-HKU1 virus (nasal aspirate) was obtained as a
clinical specimen derived from an individual suffering from an upper respiratory
tract infection. The sample was collected in March 2005 at the pediatric depart-
ment of the University Hospital of Caen, France, and is designated here as
HCoV-HKU1 strain Caen1.
Inoculation of HAE and RNA extraction. Prior to infection, the apical surfaces
of HAE were washed three times with phosphate-buffered saline (PBS) and then
inoculated via the apical surface with 200 l of a 1:2-diluted nasal aspirate or a
1:10-diluted viral stock (generated from apical washes from cultures infected
with the clinical sample isolate), which was obtained from HAE harvest at 96 h
postinfection. Following a 2-h incubation at 32°C, the unbound virus was re-
moved by washing with 500 l for 10 min at 32°C, and the HAE were maintained
at an air-liquid interface for the remainder of the experiment at 32°C. HCoV-
HKU1 replication kinetics were determined at specific time points postinocula-
tion (4, 24, 48, 72, and 96 h), 120 l of culture medium was applied to the apical
surface of HAE, and after 10 min of incubation at 32°C the apical sample was
harvested. RNA was isolated from the samples by the silica affinity-based Boom
extraction method (6) or by Trizol extraction (Invitrogen). The RNA was ana-
lyzed by real-time reverse transcriptase (RT) PCR to determine whether viral
RNA was present. RNA was also extracted from HAE by Trizol extraction to
determine the presence of viral replication-specific subgenomic (sg) mRNA
species from total cell lysates.
Real-time reverse transcriptase PCR quantification. Reverse transcription
was performed with Moloney murine leukemia virus reverse transcriptase (200 U
per reaction; Invitrogen) and 25 ng of random hexamers (Amersham Bio-
sciences) in 10 mM Tris (pH 8.3), 50 mM KCl, 0.1% Triton X-100, 5 mM MgCl2,
and 20 M each deoxynucleoside triphosphate at 37°C for 90 min in a total
volume of 40 l.
Virus yield was determined by real-time PCR, using the Platinum quantitative
PCR SuperMix–uracil-DNA glycosylase (UDG; Invitrogen). Five microliters of
cDNA was amplified in 50 l 1 Platinum quantitative PCR SuperMix–uracil-
DNA glycosylase (Invitrogen) with 125 nM MgCl2, 10 M specific probe labeled
with FAM (6-carboxyfluorescein) and TAMRA (6-carboxytetramethylrhoda-
mine), and 45 M each primer. The following primers targeting the N gene were
used for HCoV-HKU1 quantification: sense, HKUqPCR5 (5-CTGGTACGAT
TTTGCCTCAA-3); antisense, HKUqPCR3 (5-CAATCACGTGGACCCAAT
AAT-3); and probe, HKUqPCRP (5-FAM-TTGAAGGCTCAGGAAGGTCT
GCTTCTAA-TAMRA-3). Following UDG treatment for 2 min at 50°C and a
denaturation step of 10 min at 95°C, 45 cycles of amplification were performed
for 15 s at 95°C and 60 s at 60°C on a Prism 7000 real-time PCR machine (ABI).
Northern blotting. Total RNA was extracted from HCoV-HKU1-infected
HAE and purified using Oligotex mRNA spin column reagents according to the
manufacturer’s directions (Qiagen, Valencia, CA). RNA was separated on an
agarose gel using Northern-Max-Gly (Ambion/Applied Biosystems), transferred
to a BrightStar-Plus membrane (Ambion/Applied Biosystems) for 4 h, and cross-
linked to the membrane with UV light. The blot was prehybridized and probed
with an HCoV-HKU1 nucleocapsid (N)-specific oligodeoxynucleotide probe (C
CTGAACGATTTCCAGAGGAGCTbTbCTbACTb), where biotinylated nucle-
otides are designated with a superscript b. Blots were hybridized overnight and
washed with low- and high-stringency buffers as recommended by the manufac-
turer. Filters were incubated with streptavidin-alkaline phosphatase (AP),
washed, and then developed using the chemiluminescent substrate CDP-STAR.
HCoV-HKU1-active TRS elements and sg mRNA generated during viral rep-
lication. The subgenomic mRNA leader (L)-body transcription regulatory se-
quence (TRS) junctions were identified by sequencing RT-PCR-amplified cDNA
from total RNA obtained from an HCoV-HKU1-infected HAE (Trizol, Invitro-
gen). Briefly, we performed 35-cycle PCR with the 5 L primer (HKL1_5) and
gene-specific 3 primers (S gene, SL3 [ACT ACG GTG ATT ACC AAC ATC
AAT ATA]; ORF3-4L3 [CAA GCA ACA CGA CCT CTA GCA GTA AG]; E
gene, EL3 [TAT TTG CAT ATA ATC TTG GTA AGC]; M gene, ML3 [GAC
CCA GTC CAC ATT AAA ATT GAC A]; N gene, 3-163-F15 [ATT ACC TAG
GTA CTG GAC CT]), which were designed from full-length sequence and
predicted annotations of downstream open reading frames (ORFs) and putative
leader-body junctions as previously described in the literature (36, 60). After
amplification, the sample was analyzed by electrophoresis on a 0.8% agarose gel
and products of discrete sizes were used for sequencing by using the BigDye
Terminator kit (ABI) and a model 3100 genetic analyzer (Applied Biosystems).
Raw data were processed and analyzed with CodonCode Aligner version 1.52
software (CodonCode Corporation).
Antibody blockade assay. To determine whether HCoV-HKU1 infection of
HAE required human leukocyte antigen C (HLA-C) (8), the apical surfaces of
HAE were rinsed and 300 l of a 1:10 dilution of monoclonal anti-HLA-C (Santa
Cruz), a mixture of monoclonal anti-HLA-B/C (Santa Cruz), or a control anti-
body (anti-angiotensin-converting enzyme 2 [ACE2]) (45) was applied to the
apical surfaces of HAE. After 2 h incubation, excess antibody was removed and
HCoV-HKU1 (200 l stock virus diluted 1:1,000) was inoculated onto the apical
surface and incubated for an additional 2 h at 32°C. Viral inocula were then
removed, cultures were washed, and 30 l of the original diluted antiserum was
returned to the apical surface of HAE. Apical washes were collected at 6, 20, 30,
44, 54, and 72 h postinoculation, RNA was extracted, and titers were assessed by
real-time PCR.
Microscopy studies. For detection of HCoV-HKU1 antigens in HAE, cultures
inoculated with HCoV-HKU1 (105 genome copies/ml) were fixed in 4% para-
formaldehyde (PFA) for 24 h, transferred to 70% ethanol, and prepared as
paraffin-embedded histological sections by the UNC Cystic Fibrosis Center Mor-
phology and Morphometrics Core. After deparaffinization, histological sections
were incubated for 1 h in phosphate-buffered saline (PBS) containing 3% bovine
serum albumin (BSA). Primary antibodies (rabbit polyclonal serum directed
against whole mouse hepatitis virus virions, kindly provided by Mark Denison at
Vanderbilt University, and mouse monoclonal serum directed against -tubulin
IV [Sigma]) were applied at a 1:50 dilution in PBS with 1% BSA for 2 h and
detected with anti-rabbit antibody conjugated to Alexa 488 (Invitrogen) or anti-
mouse antibody conjugated to Alexa 594 (Invitrogen). Rabbit preimmune serum
was used as a control for the immune serum. Immunofluorescence was visualized
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with a Leica Leitz DM IRB inverted fluorescence microscope equipped with a
cooled color charge-coupled digital camera (MicroPublisher; QImaging).
For visualization of virus by transmission scanning electron microscopy, HAE
were apically inoculated as described above, and cultures were fixed in 2%
PFA-0.2% glutaraldehyde at 72 h postinoculation exactly as previously described
(45).
Full genome sequencing. HCoV-HKU1 strain Caen1 RNA was reverse tran-
scribed as described above and amplified in a 35-cycle PCR with sets of primers
covering the complete genome (primer sequences are available upon request).
Amplicons ranging in size from 96 to 660 bp were analyzed on the 0.8% agarose
gel and purified, and discrete products were subjected to sequencing. Sequence
reactions were performed without column purification, according to the manu-
facturer’s protocol for BigDye Terminator version 1.1 cycle sequencing. Electro-
phoresis and data collection were performed employing a model 3100 genetic
analyzer (Applied Biosystems). Raw data were processed and analyzed with the
CodonCode Aligner version 1.52 software (CodonCode Corporation).
Phylogenetic comparison of HKU1 genomes. Selected genomes from different
HKU1 strains were downloaded from GenBank and compared by multiple se-
quence alignment using ClustalX version 2.011 (26).
Maximum likelihood phylogenetic trees were generated using the PhyML
program (20) as implemented in the Geneious package. All trees were generated
using the MtREV substitution model with estimated transition/transversion ra-
tios for DNA models and the proportion of invariable sites fixed at zero. Boot-
strapping was conducted and generated 100 bootstrapped data sets, and a con-
sensus tree was generated using Consensus from the Phylip package (16). Trees
were visualized in the Geneious tree viewer, and the Seaview (19) tool was used
for editing and rearranging branches. Sequences selected for comparison
included AY597011.2, HKU1_A; AY884001.1, HKU1_B; DQ415896.1,
HKU1.N19; DQ415897.1, HKU1.N20; DQ415898.1, HKU1.N21; DQ415899.1,
HKU1.N22; DQ415900.1, HKU1.N23; DQ415902.1, HKU1.N25; DQ415903.1,
HKU1.N3; DQ415904.1, HKU1.N6; DQ415905.1, HKU1.N7; DQ415906.1,
HKU1.N9; DQ415907.1, HKU1.N10; DQ415908.1, HKU1.N11; DQ415909.1,
HKU1.N13; DQ415910.1, HKU1.N14; DQ415911.1, HKU1.N15; DQ415912.1,
HKU1.N16; DQ415913.1, HKU1.N17; and DQ415914.1, HKU1.N18,
NC_006577.2, HKU1.
Nucleotide sequence accession number. The complete genome sequence of
HCoV-HKU1 strain Caen1 was deposited in GenBank (accession number
HM034837).
RESULTS
HCoV-HKU1 replication kinetics in HAE. HCoV-HKU1
was identified in clinical isolates as a human coronavirus in
2005. RNA isolated from clinical samples provided the basic
gene order of the HCoV-HKU1 genome and the number of
putative viral subgenomic RNA species (Fig. 1). However, all
efforts to culture this virus in traditional human and nonhuman
cell lines have proven unsuccessful. Previous studies in our
laboratory and those of others have demonstrated that in vitro
models of well-differentiated airway epithelial cells, including
those for human lung cells (HAE), provide a robust model
system for studying replication and pathogenesis of human
coronaviruses, including SARS-CoV, HCoV-NL63, HCoV-
229E, and HCoV-OC43 (3, 13, 45, 56). We and others have
shown that such cell models make an excellent primary cultur-
ing resource for propagating respiratory virus isolates (3, 11,
13, 45).
To determine if HAE could be utilized to propagate the
HCoV-HKU1, the apical surface of HAE was inoculated and
incubated for 2 h at 32°C with a clinical sample containing
HCoV-HKU1 from France in 2005 (strain Caen1). For the
passage 1 sample, RNA was extracted from both apical washes
and basolateral medium at 96 h postinoculation. Real-time
reverse transcriptase PCR analysis of apical medium demon-
strated an increase in genome copy numbers 96 h postinocu-
lation (Fig. 2A), the first indication that HCoV-HKU1 in clin-
ical isolates was infectious and could replicate in an in vitro
model. Subsequent passages were performed by inoculating
virgin cultures with the 96-h apical wash from the previous
FIG. 1. HCoV-HKU1 genome and subgenomic RNA species sche-
matic. All open reading frames (ORFs) in the HCoV-HKU1 genome
are shown as rectangles in the top schematic, and the proteins ex-
pressed from each are indicated. Viral leader sequences are shown as
small yellow rectangles at the 5 end of each line representation of the
viral subgenomic RNA species at the bottom of the figure. The 5-most
ORF is translated from each subgenomic RNA, and this ORF is
indicated as a colored rectangle for each RNA. UTR, untranslated
region; HE, hemagglutinin; S, spike; AP, accessory open reading
frame/protein; E, envelope; M, membrane; N, nucleocapsid.
FIG. 2. (A) Replication of an HCoV-HKU1 clinical isolate in
HAE. HAE were inoculated with diluted nasal aspirates for the first
passage (108 copies/ml) and with apical washes from 96 h postinocu-
lation for the subsequent passage. The bars represent real-time PCR
analysis of apical media harvested from HCoV-HKU1-infected HAE
at 96 h postinoculation or from the inoculating clinical sample.
(B) Replication kinetics of HCoV-HKU1 in HAE. Cultures were in-
oculated with passage 3 virus (108 copies/ml). Data points represent
real-time PCR of apical washes from HCoV-HKU1-infected HAE,
harvested at the indicated times postinoculation. Data are presented as
HCoV-HKU1 RNA copies/ml and are representative of results from
experiments performed in duplicate.
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passage. No virus was detected in the basolateral compart-
ments of HAE (data not shown), suggesting that virus shed
only from the apical surface, a finding consistent with previous
reports of other human coronaviruses in this culture model (3,
45, 56). In addition, these experiments demonstrated that the
genome copies detected in the apical wash were infectious and
did not represent defective particles, confirming active HCoV-
HKU1 replication in HAE (Fig. 2A).
Having demonstrated increased genome copy numbers for
HCoV-HKU1 following inoculation of the apical surface of
HAE, we next determined the viral replication kinetics.
HCoV-HKU1 viral stocks were used to inoculate the apical
surfaces of HAE, and at 4, 24, 48, 72, and 96 h postinoculation,
apical surfaces were washed, harvested directly for RNA, and
assayed by real-time reverse transcriptase PCR for the pres-
ence of HCoV-HKU1 RNA. During the 7 days of incubation,
we observed no major morphological changes in HAE nor any
obvious cytotoxicity or leakage of basolateral media into the
apical compartment, suggesting that the epithelial cell layer
integrity was maintained. Multilog increases in viral genome
copies were detected over the course of infection, providing
the first evidence for an in vitro replication model for HCoV-
HKU1 (Fig. 2B). Viral genome copy numbers increased rap-
idly from 4 h postinoculation, reaching peaks of 109 cop-
ies/ml within 72 h and maintaining those copy numbers at 96 h
postinfection.
Analysis of HCoV-HKU1 subgenomic mRNA synthesis in
HAE. One distinction of the Coronaviridae is the synthesis of a
nested set of subgenomic mRNAs (sg mRNAs) via a mecha-
nism called discontinuous transcription (Fig. 1) (4, 39, 40).
These subgenomic RNAs serve as the templates for the trans-
lation of structural and accessory proteins. We employed
Northern blot analysis with a probe specific to the nucleocapsid
sequence to assess the number and size of the HCoV-HKU1
subgenomic mRNA species. Five distinct RNA species were
identified, with the sizes indicating the presence of RNA mol-
ecules corresponding to the hemagglutinin (HE; 8,226 nu-
cleotides [nt]), spike (S; 7,056 nt), membrane (M; 2,368
nt), and nucleocapsid (N; 1,685 nt) structural sg mRNA as
well as one species for the accessory open reading frame (AP;
2,954 nt) between spike and membrane, confirming all pre-
viously predicted HCoV-HKU1 subgenomic mRNAs (Fig. 3)
(57).
To confirm the expression profile of sg mRNA during active
virus replication, we employed a standard RT-PCR amplifica-
tion technique to detect the presence of subgenomic mRNAs
which were formed by the joining of 5 genomic leader RNA
sequences to the body sequences of each subgenomic mRNA
(Fig. 1) (39). We used a common 5 leader RNA primer and
multiple 3 primers targeting the first 100 nucleotides of each
predicted gene. The PCR amplification products were then
separated by electrophoresis on a 0.8% agarose gel, and the
DNA was visualized using ethidium bromide on a Dark
Reader (Clare Chemical). Bands were detected for sub-
genomic mRNA corresponding to the 1a, HE, S, AP, M, and N
genes (Fig. 4A). Of note, a specific subgenomic mRNA corre-
sponding to the envelope (E) gene was not amplified, as ex-
pected from the in silico TRS analysis (57). Sequence analysis
of the subgenomic mRNA PCR products revealed that all
subgenomic mRNAs do contain the HCoV-HKU1 5-end
leader sequence (Fig. 4C).
We also investigated the levels of S, M, and N subgenomic
mRNA synthesis during infection employing a semiquantita-
tive RT-PCR. Total RNA was harvested from HCoV-HKU1-
infected HAE at 36 and 96 h postinoculation. RNA was ana-
lyzed by RT-PCR optimized to detect the multiple subgenomic
RNA species containing the ORF of interest (Fig. 1). These
data and our Northern blot analysis indicated that HCoV-
HKU1 used transcription kinetics similar to that of other hu-
man coronaviruses with higher levels of the more 3 ORFs, N
and M subgenomic RNA (Fig. 3 and 4B). In contrast, we were
not able to detect S subgenomic RNA at 36 h postinoculation
and only the 96-h postinoculation sample was positive (Fig.
4B). These results are consistent with previous studies demon-
strating that 3-proximal transcripts are typically more abun-
dant in coronavirus-infected cells (10, 36).
Sequencing of the HCoV-HKU1 Caen1 genome. To charac-
terize the HCoV-HKU1 isolate replicating in HAE, we se-
quenced the entire viral genome by using primer sets designed
with sufficient overlap to verify the data for the complete ge-
nome. The genome was 29,926 nucleotides (nt) in length and
comprised 8 genes (1a/b, HE, S, ORF4, E, M, N, N2). Phylo-
genetic analysis clearly shows that the Caen1 isolate clusters
with other group A isolates (Fig. 5). Comparative genome
analysis with the reference strains did not reveal any apparent
deviations, suggesting that a recombination event had not oc-
curred nor had there been extensive alteration of the sequence
by insertions and/or deletions. The S gene had99.6% identity
with other group A HCoV-HKU1 isolates.
HCoV-HKU1 cellular localization and egress during infec-
tion of HAE. To determine the HAE cell type(s) infected by
HCoV-HKU1, we inoculated HAE cultures with HCoV-
HKU1 and fixed the cultures in 4% PFA 96 h postinoculation.
Cultures were then processed for immunofluorescence assays
as previously described (45). Sections were probed with a
monoclonal antibody against a ciliated cell-specific marker,
-tubulin IV, to identify ciliated cells and rabbit antiserum
FIG. 3. HCoV-HKU1 RNA species present during infection of
HAE. Representative Northern blot analysis for total RNA isolated
from HCoV-HKU1-infected HAE. RNA species are indicated by ar-
rows to the right of the autoradiograph. HE, hemagglutinin; S, spike;
ORF 4, accessory open reading frame; E, envelope; M, membrane; N,
nucleocapsid; N2, internal ORF in N. (A) Total RNA, 0.1 g; (B) total
RNA, 1 g.
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generated against mouse hepatitis virus (MHV) whole virions:
this antibody was used to detect HKU1 due to the significant
sequence homology between the N proteins of MHV and
HCoV-HKU1 N (70%) and because HCoV-HKU1 antibod-
ies were not currently available. HKU1 immunoreactivity was
detected only in sections of HAE inoculated with HCoV-
HKU1, and colocalization of HKU1 and -tubulin IV indi-
cated that ciliated cells were infected by HKU1 (Fig. 6A). No
immunoreactivity for HKU1 was detected in sections of
HCoV-HKU1-inoculated HAE probed with preimmune rabbit
serum (Fig. 6B) or HAE not inoculated with HKU1 (not
shown). Overall, significant numbers of ciliated cells were in-
fected by HKU1, indicating robust and ciliated cell-specific
infection of HAE by this virus.
To confirm the cellular localization of HCoV-HKU1 repli-
cation and egress during infection of HAE, cultures were in-
oculated with HCoV-HKU1 (Fig. 7C to G) or mock inoculated
(Fig. 7A and B) for 72 h and then processed for transmission
electron microscopy. These studies revealed large numbers of
viral particles in the apical compartment of HAE, largely as-
sociated with the apical surface of ciliated cells (Fig. 7C to G).
Viruses associated with the microvilli and cilial shafts and were
present in the airway surface liquid microenvironment. The
localization of HCoV-HKU1 to ciliated cell apical structures is
similar to the previously reported localization of SARS-CoV
after infection of HAE (Fig. 7C to G). Although fewer num-
bers of viral particles were observed inside cells, when present,
virions were observed in vesicular structures in the cytoplasm
of ciliated cells (Fig. 7D, box). These data further support our
immunofluorescence studies showing that HCoV-HKU1 rep-
licates in ciliated cells of HAE, the same cells infected by all
other human coronaviruses tested to date.
Antibody blockade assay. Recent studies using viral pseu-
doparticles containing HCoV-HKU1 spike protein have sug-
gested that HCoV-HKU1 uses the major histocompatibility
complex class I C/human leukocyte antigen C (HLA-C) as a
receptor for entry into permissive cells (8). To determine
whether HCoV-HKU1 utilizes HLA-C as a receptor in HAE
cultures, the apical surfaces of cultures were incubated either
individually or in combination with a monoclonal antibody for
HLA-C or a monoclonal antibody that detects both HLA-B
and HLA-C for 3 h prior to inoculation. To ensure the validity
of results, the same antibodies as previously reported by Chan
et al. (8) to block entry of HCoV-HKU1 spike pseudoparticles
FIG. 4. HCoV-HKU1 subgenomic species. (A) Subgenomic
mRNA species generated during HCoV-HKU1 replication in HAE.
Each lane contains RT-PCR products from total RNA isolated from
HCoV-HKU1-inoculated HAE, amplified using a 5 HCoV-HKU1
leader primer and the indicated ORF-specific 3 primer. Size markers
are indicated on the far left of the gel, and the size of each band is
shown at the base of each well. 1a, open reading frame 1a replicase
proteins; HE, hemagglutinin; S, spike; AP, accessory open reading
frame 4/protein; E, envelope; M, membrane; N, nucleocapsid. (B) Ki-
netics of subgenomic RNA species synthesis during HCoV-HKU1
replication in HAE. Each lane contains RT-PCR bands from RNA
extracted from HCoV-HKU1-inoculated HAE for the first 500 nt of
the structural proteins spike, membrane, and nucleocapsid. Marker
sizes are indicated between the gels, times postinoculation are indi-
cated above each well, and the gene of interest is indicated at the base
of each gel. S, spike; M, membrane; N, nucleocapsid. (C) Leader-body
junctions of all HCoV-HKU1 sg mRNAs. Shown on the top row is the
leader (L) sequence, and the bottom row shows the specific sequences
upstream of the structural genes (G). The sequence in the middle (sg)
represents the mature sg mRNA generated during coronavirus repli-
cation. Sequence homology between the strands near the junction is
highlighted in black. HE, hemagglutinin; S, spike; ORF4, accessory
open reading frame; E, envelope; M, membrane; N, nucleocapsid; N2,
internal ORF in N.
FIG. 5. Maximum likelihood cladogram of HKU1 genomes.
HCoV-HKU1 strain Caen1 was compared to 23 additional full-length
HCoV-HKU1 virus genomes to determine its evolutionary relatedness
within the HCoV-HKU1 lineage. This maximum likelihood tree gen-
erated with the PhyML package shows that HCoV-HKU1 strain Caen1
is most closely related to the A genotype. Branch points are labeled
with bootstrap values, based upon 100 iterations, and the cladogram is
set to be proportional.
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into permissive cells were used. We have previously used this
approach with HAE to successfully ablate SARS-CoV infec-
tion using antibodies to block virus binding to angiotensin
converting enzyme 2 (ACE2) (45). In the continued presence
of HLA or ACE2 antibodies, HAE were inoculated with
HCoV-HKU1 (stocks diluted 1:1,000) and apical washes were
collected over time until 72 h postinoculation. RNA was iso-
lated from the apical washes, and samples were analyzed by
real-time reverse transcriptase PCR. These data demonstrated
that viral genomic RNA increased over time for all treatment
groups at all time points, indicating that the presence of anti-
body, whether control (ACE2) or directed against HLA-C or
HLA-B/C, had no effect on virus replication kinetics (Fig. 8).
Based on these results, we suggest that in HAE, a relevant
human ciliated airway epithelium model, HLA-C is not an
absolute requirement for efficient HCoV-HKU1 infection.
DISCUSSION
To date, five human coronavirus strains have been identified
(HCoV-229E, HCoV-OC43, SARS-CoV, HCoV-NL63, and
HCoV-HKU1), and all have been associated with mild to se-
vere respiratory tract illnesses. Although more recent epide-
miologic studies have demonstrated a significant association
with respiratory tract infections (12, 25, 52), HCoV-229E and
HCoV-OC43 were first described in the mid-1960s as human
coronavirus strains that caused relatively mild common cold
symptoms (21, 30, 50). The previously considered mild nature
of human coronavirus-associated respiratory disease was revis-
ited after the isolation of SARS-CoV in 2003 in the Guandong
province of China (14, 24, 33). SARS-CoV was the first human
coronavirus strain that caused lethal infections in otherwise
healthy individuals. Soon after the SARS-CoV epidemic was
controlled in early July 2003 by stringent quarantine measures,
HCoV-NL63 was identified in 2004, employing a novel VI-
DISCA tool from patients presenting with bronchiolitis (37,
54). HCoV-NL63 is currently associated with croup and respi-
ratory illness, causing significant illness in infants, the immu-
nocompromised, and elderly patients (34, 53–55). Another hu-
man coronavirus strain, HCoV-HKU1, was identified in 2005
by direct analysis of clinical samples from patients with respi-
ratory infections using degenerate primer-based PCR tech-
niques (57). HCoV-HKU1-positive samples have been de-
tected worldwide, and the virus has been shown to cause a wide
variety of respiratory tract disease symptoms and severity of
disease (7, 35, 48, 51, 57). A previous report by Chan et al. has
proposed that HCoV-HKU1 utilizes HLA-C for cell attach-
ment and entry; however, despite significant efforts, HCoV-
HKU1 had proven unculturable using laboratory-based cell
lines in vitro (8).
We hypothesized that the successful infection and replica-
tion of HCoV-HKU1 clinical isolates in vitro require a plat-
form that more accurately reproduces the environment of the
human airway epithelium, a likely initial site for coronavirus
inoculation and spread. We have achieved this goal using a
human ciliated airway epithelial cell model. This in vitro cul-
ture model is derived from freshly isolated human tracheo-
bronchial airway epithelial cells and mirrors the morphology
and physiology of the human cartilaginous airway epithelium.
Following 6 to 8 weeks of cell culture growth, a fully differen-
tiated respiratory epithelium is established, with predominant
ciliated cells interspersed with goblet cells overlying a basal
epithelial cell population. This model system has been shown
previously to support infection and replication of a number of
human respiratory viruses, including parainfluenza viruses, in-
FIG. 6. HCoV-HKU1 infects ciliated cells of HAE. Representative images of HCoV-HKU1 immunoreactivity in histological sections of HAE
72 h postinoculation with HCoV-HKU1. Histological sections were probed with antisera directed against mouse hepatitis virus (MHV) whole
virions (green) and -tubulin IV (red). (A) HCoV-HKU1 immunoreactivity (green) in histological sections, demonstrating that HCoV-HKU1
infects ciliated cells. (B) HCoV-HKU1-inoculated HAE probed with preimmune rabbit serum and -tubulin IV antibody, demonstrating no
HCoV-HKU1 immunoreactivity. Original magnification, 40. Scale bars, 100 m; red arrows, cilial shafts of ciliated cells; green arrow,
HKU1-infected cells; white arrows, basal cells present on the Transwell supports. Colocalization of HCoV-HKU1 and ciliated cell immunoreac-
tivity (greenish-yellow) indicate ciliated cell infection by HCoV-HKU1.
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fluenza viruses, respiratory syncytial virus (RSV), human meta-
pneumovirus, human bocavirus, and coronaviruses (2, 3, 5, 11,
13, 30, 42, 45, 56, 61). Here, we demonstrate for the first time
that this model provides a relevant and appropriate cellular
environment conducive for the successful infection and growth
of HCoV-HKU1. HAE cultures have been previously identi-
fied as an excellent culture system for propagation of clinical
isolates (11), and here we show that HAE represents the only
culture system tested so far that supports HCoV-HKU1 infec-
tion and replication. Furthermore, previous studies from our
laboratory based on other coronavirus strains have demon-
strated that passage of virus in HAE adapts the virus for better
growth in human cell lines (44). Despite this, we have still been
unable to generate HAE-derived HCoV-HKU1 stocks that are
capable of replication on LLC-MK2, VeroE6, or Calu3 cell
lines (data not shown).
We also demonstrate that HCoV-HKU1 does not require
FIG. 8. Efficient infection of HAE by HCoV-HKU1 does not re-
quire HLA-C. Replication kinetics of HCoV-HKU1 were assessed by
real-time RT-PCR of RNA present in apical washes from HCoV-
HKU1-infected HAE cultures pretreated with either no antibody (yel-
low), HLA-C-specific antibody (blue), HLA-BC antibody (pink), a
combination of the antibodies (green), or ACE2 antibody (black).
Titers are represented by virus copies per milliliter. No significant
differences in HCoV-HKU1 infection and replication were measured
in any treatment group. n  3 for each treatment group.
FIG. 7. Ultrastructural localization of HCoV-HKU1 in HAE. Representative transmission electron photomicrographs of HAE inoculated with
HCoV-HKU1. (A and B) HAE mock inoculated with the vehicle alone, demonstrating the typical morphological features of the apical surfaces
of HAE with cilia (black arrows) and microvilli (white arrows). (C to G) HAE infected with HCoV-HKU1 for 96 h showing the presence of the
large numbers of virions (circled) associated with the surfaces of ciliated cells or shed into pericilial regions (black arrows, cilia; white arrows,
microvilli). Intracellular virions were also noted inside vesicular structures in the cytoplasm of ciliated cells (D, box). F represents a high-power
image of a virion associated with the tip of a microvillus. Scale bars are shown in the lower right of each panel and represent 2 m in panels A
to D and G and 1 m in panels E and F.
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the HLA-C molecule for efficient infection, contradicting pre-
viously published data. As reported by Chan et al., HLA-C on
the surface of A549 cells greatly increased the rate of attach-
ment of HCoV-HKU1 spike containing pseudotyped particles
but was not sufficient for entry of these particles into any cell
line tested (8). In our studies, using the same blocking anti-
bodies as Chan et al., we were unable to reduce HCoV-HKU1
infection in HAE. Consistent with these findings, we have also
found that HCoV-HKU1 replication was not detected in cell
lines expressing HLA-C (data not shown), suggesting that ad-
ditional coreceptors may be required or that replication of
HCoV-HKU1 is not supported in these cells due to particular
cell line characteristics. In the present study, antibodies against
HLA-C or ACE2 did not reduce HCoV-HKU1 infection of
HAE. While anti-ACE2 antibody can interfere with SARS-
CoV or HCoV-NL63 docking and entry into cells, the HLA-C
antibodies did not prevent HKU1 infection. Further work to
study HLA-C and/or identify the HCoV-HKU1 receptor(s) for
docking and entry will be required to clarify the entry mecha-
nisms and receptor complexes used by HCoV-HKU1 for entry
into HAE.
Robust HCoV-HKU1 replication provided a model to iden-
tify the subgenomic mRNA molecules synthesized during in-
fection and revealed a characteristic coronaviral discontinuous
replication process (4, 38–40, 46). HCoV-HKU1 replication
results in the production of five subgenomic mRNA species,
corresponding to genes HE, S, AP, M, and N, as reported
previously based on in silico studies. Genome organization is
similar to that of the other group 2 human coronavirus, HCoV-
OC43. We were not able to detect an E sg mRNA in infected
cells, which agrees with a previous report on the absence of a
transcription regulatory sequence (TRS) specific for the E
gene (57). The E protein forms pores and plays a role in
membrane contortion during virus assembly and release. The
E protein is absolutely essential for the production of group 1
coronavirus particles; however, group 2 coronaviruses, like
SARS-CoV and MHV, can replicate in the absence of the E
protein (9, 32). Although speculative, the E gene may be ex-
pressed by either a translation-scanning mechanism or by in-
ternal ribosome entry sites. Both strategies are employed by
other coronaviruses to express specific downstream ORFs (15,
28, 29, 31, 43, 49, 58). Sequence analysis of the amplified
leader-body fusion mRNA molecules revealed that the core
TRS is indeed AAUCUAAAC, as predicted, and is present in
the 5 region of all identified mRNA molecules (57).
Electron micrographs and immunofluorescence data with
HCoV-HKU1-infected HAE indicate that HCoV-HKU1, like
all human coronaviruses studied to date, infects and replicates
efficiently within ciliated cells of HAE and that virus is released
only from the apical surface of the cultures. We continue to
study the relevance of ciliated cell infection by these and other
respiratory viruses.
In conclusion, we have established an in vitro culture system
for culturing HCoV-HKU1, the most fastidious human coro-
navirus identified to date. Little is known about the replication
or pathogenesis characteristics of this virus, since previous
research was limited to analysis of clinical isolates. Future
studies on HCoV-HKU1 will focus on the identification of the
HCoV-HKU1 cellular receptor in the appropriate models, rep-
lication strategies of the virus, and evaluation of potential
anticoronavirus drugs. Development and evaluation of a cul-
ture system such as HAE as described in this study represents
a milestone in the ongoing research on this relatively new
member of the Coronaviridae family.
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